Early versus Delayed Hepatitis B Vaccine Administration in Preterm Infants <32 weeks Gestation: Effects on Seroconversion and Adverse>Effects

Jessica Walker, Thomas Jefferson University

Document Type Poster

Presented at the Graduate Project Poster Symposium.

Abstract

Research Question

In preterm infants born < 32 weeks gestation admitted to the NICU, does administration of the Hepatitis B vaccine at birth, compared with delayed administration at >/= 37 weeks corrected gestational age, result in affects to seroconversion rates and adverse effects?